323 related articles for article (PubMed ID: 21549089)
1. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
Rallis E; Verros CD
Dermatol Online J; 2011 Apr; 17(4):14. PubMed ID: 21549089
[No Abstract] [Full Text] [Related]
2. Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Carlesimo M; La Pietra M; Arcese A; Di Russo PP; Mari E; Gamba A; Orsini D; Camplone G
Int J Dermatol; 2012 Oct; 51(10):1234-6. PubMed ID: 22416995
[No Abstract] [Full Text] [Related]
3. Combining traditional agents and biologics for the treatment of psoriasis.
Cather JC; Menter A
Semin Cutan Med Surg; 2005 Mar; 24(1):37-45. PubMed ID: 15900797
[TBL] [Abstract][Full Text] [Related]
4. Childhood psoriasis: often favorable outcome.
Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
[TBL] [Abstract][Full Text] [Related]
5. A global approach to psoriatic patients through PASI score and Skindex-29.
Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab vs. etanercept in psoriasis.
Downs AM
Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
[No Abstract] [Full Text] [Related]
7. Vitamin D and systemic therapy.
van de Kerkhof P
Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
Chu DH; Van Voorhees AS; Rosenbach M
Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
[No Abstract] [Full Text] [Related]
9. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
10. [What is the impact of the new clinical trial data? What are the lessons for patient management?].
Passeron T; Boulinguez S
Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):11-5. PubMed ID: 20510174
[No Abstract] [Full Text] [Related]
11. Potential future therapies for psoriasis.
Papp KA
Semin Cutan Med Surg; 2005 Mar; 24(1):58-63. PubMed ID: 15900800
[No Abstract] [Full Text] [Related]
12. Anti-TNF-alpha therapy in childhood pustular psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
[No Abstract] [Full Text] [Related]
13. [Psoriasis].
Guilhou JJ; Girard C
Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
[No Abstract] [Full Text] [Related]
14. [Intermittent treatment regimens and the rational (efficient) use of biologic agents in psoriasis].
Moreno-Ramírez D
Actas Dermosifiliogr; 2011 May; 102(4):241-3. PubMed ID: 21481332
[No Abstract] [Full Text] [Related]
15. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
Takeshita J; Wang S; Shin DB; Callis Duffin K; Krueger GG; Kalb RE; Weisman JD; Sperber BR; Stierstorfer MB; Brod BA; Schleicher SM; Robertson AD; Linn KA; Shinohara RT; Troxel AB; Van Voorhees AS; Gelfand JM
J Am Acad Dermatol; 2014 Dec; 71(6):1167-75. PubMed ID: 25260564
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of psoriasis].
Lauharanta J
Duodecim; 1993; 109(5):441-7. PubMed ID: 8020412
[No Abstract] [Full Text] [Related]
17. The return of investment of translational research in inflammatory dermatoses.
van de Kerkhof PC
J Dermatolog Treat; 2008; 19(6):317. PubMed ID: 18982511
[No Abstract] [Full Text] [Related]
18. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
Woolf RT; Smith CH; Robertson K; Barker JN
Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
[No Abstract] [Full Text] [Related]
19. Efficacy of ustekinumab in palmoplantar psoriasis.
Bulai Livideanu C; Lahfa M; Mazereeuw-Hautier J; Paul C
Dermatology; 2010; 221(4):321-3. PubMed ID: 20980724
[No Abstract] [Full Text] [Related]
20. Switching biologics for psoriasis.
Ormerod AD
Br J Dermatol; 2010 Oct; 163(4):667-9. PubMed ID: 20854399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
